Document:

exv4w2

 

Exhibit 4.2

 

	 	 	 	 
	 
	 	 	PricewaterhouseCoopers LLP
	 
	 	 	Chartered Accountants
	 
	 	 	PO Box 82
	 
	 	 	Royal Trust Tower, Suite 3000
	 
	 	 	Toronto Dominion Centre
	 
	 	 	Toronto, Ontario
	 
	 	 	Canada M5K 1G8
	 
	 	 	Telephone +1 416 863 1133
	 
	 	 	Facsimile +1 416 365 8215

CONSENT OF INDEPENDENT AUDITORS

We hereby consent to the reference to our firm under the caption “Experts” in the Registration
Statement on Form F-8 (File No. 333-129218) filed with the United States Securities and Exchange
Commission, as amended on December 15, 2005, January 20,
2006, February 28, 2006 and on or about
May 29, 2006, to the incorporation by reference therein of our report dated February 28, 2006 relating to the consolidated financial statements, and the financial statement
schedule of Inco Limited as at December 31, 2005, 2004 and 2003 and for each of the years in the
three-year period ended December 31, 2005 and management’s assessment of the effectiveness of
internal control over financial reporting and the effectiveness of internal control over financial
reporting as at December 31, 2005 which appears on page 143 of Inco Limited’s Annual Report on Form
10-K for the year ended December 31, 2005.

/s/ PricewaterhouseCoopers LLP

Chartered Accountants

Toronto, Ontario

May 29, 2006

PricewaterhouseCoopers refers to the Canadian firm of PricewaterhouseCoopers LLP and the other
member firms of PricewaterhouseCoopers International Limited, each of which is a separate and
independent legal entity.exv4w3

 

Exhibit 4.3

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption “Experts” in the Registration Statement
(Form F-8) (File No. 333-129218), as amended on
December 15, 2005, January 20, 2006, February 28,
2006 and May 31, 2006 (the “Amended Registration
Statement”), pertaining to Inco Limited’s offer dated
October 24, 2005 to
purchase all of the issued and outstanding common shares of Falconbridge Limited (formerly Noranda
Inc.) (the “Company”) and the incorporation by reference in the Amended Registration Statement of our
auditors’ report dated  February 7, 2006 (except as to
Note 23 which is as of March 16, 2006) relating to the consolidated balance sheets of the Company
as at December 31, 2005 and 2004, and the consolidated statements of income and retained
earnings (deficit) and cash flows for the years then ended.

	 	 	 
	 

	 	/s/ Ernst & Young LLP
	Toronto, Canada,
	 	 
	May 29, 2006

	 	Chartered Accountants$3,000,000.00                                                       May   , 2006

                           BUSINESS PROMISSORY NOTE
                           ------------------------

     FOR VALUE RECEIVED,  Synovics  Pharmaceuticals,  Inc., a Nevada corporation
("Borrower"),  promises to pay to the order of John S. Copanos ("LENDER"), Three
Million Dollars ($3,000,000.00),with interest, as provided herein.

     1.   PRINCIPAL PAYMENTS.  The principal amount of this Note shall be due in
a lump sum three (3) years from the date hereof (the "Maturity Date").

     2.   PREPAYMENTS.  Principal  amounts  outstanding  under  this Note may be
prepaid  at any time at the  option of  Borrower,  in whole or in part,  without
premium or penalty.

     3.   INTEREST  PAYMENTS.  This  Note  shall  bear  interest  on the  unpaid
principal balance from the date hereof at the rate of seven and one half percent
(7 1/2%) per annum,  payable on the date twelve (12) months from the date hereof
and each twelve (12) months thereafter until the Maturity Date.

     4.   METHOD OF PAYMENT.  All  payments of principal  and interest  shall be
made by the transfer of  immediately  available  funds to such account as Lender
shall designate from time to time. If any payment date shall fall on a day other
than a business  day,  the payment due on such date shall be payable on the next
succeeding business day.

     5.   DEFAULT.  A default  shall  exist upon the  failure by Borrower to pay
when due the interest on the unpaid  principal  evidenced  by this Note,  upon a
failure to comply with any of the other terms, provisions and conditions of this
Note,  or upon a  failure  to pay the  principal  when  due,  and  such  default
continues for a period of sixty (60) days following  written notice from Lender.
If at any time Lender incurs costs in respect of the collection of  indebtedness
hereunder,  including attorneys' fees and expenses,  Lender shall be entitled to
immediate reimbursement from the Borrower for all such costs incurred (or at his
option elect to add such amounts to the principal balance of the indebtedness).

     6.   GOVERNING  LAW.  This  Note  shall be  governed  by and  construed  in
accordance  with the laws of the State of  Florida  excluding  the  conflict  or
choice of law principles  thereof,  and any suit brought in connection  with the
enforcement or  interpretation  of this Note may be brought in the courts of the
State of Florida or the federal courts in Florida.  Borrower hereby  irrevocably
submits to the non-exclusive jurisdiction of such courts.

     7.   MISCELLANEOUS.  Presentment,  notices of dishonor and demand,  protest
and diligence in collection and bringing suit are hereby severally waived by the
Borrower.  No waiver of any default or failure or delay to exercise any right or
remedy by the holders of

<PAGE>

this Note shall  operate as a waiver of any right or remedy with  respect to the
same or any other occurrences.  This written Note represents the final agreement
between  the  parties  and  my  not  be   contradicted  by  evidence  of  prior,
contemporaneous,  or subsequent,  oral  agreements of the parties.  There are no
unwritten oral agreements between the parties.

     8.   WAIVER OF JURY TRIAL.  IN ANY COURT ACTION RELATING TO THIS NOTE, EACH
OF BORROWER AND LENDER WAIVES ANY RIGHT TO TRIAL BY JURY.

     IN WITNESS  WHEREOF,  Borrower  has caused  this Note to be executed by its
duly authorized officers.

                                            SYNOVICS PHARMACEUTICALS, INC.

Attest:

                                            By: /s/ Ronald Howard Lane
                                                --------------------------------
                                                     Ronald Howard Lane, PhD
                                                     Chairman, CEO and President

[illegible]
-----------
Secretary

                                     NOTICE

THIS NOTE HAS NOT BEEN  REGISTERED  PURSUANT TO THE  SECURITIES  ACT OF 1933, AS
AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE MAY NOT BE OFFERED
OR SOLD UNLESS IT IS REGISTERED  UNDER THE APPLICABLE  SECURITIES LAWS OR UNLESS
AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE.<PAGE>
                                                                     Exhibit 4.1

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE
SECURITIES LAWS AND NEITHER SUCH SHARES NOR ANY INTEREST THEREIN MAY BE OFFERED,
SOLD, PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION
STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY
APPLICABLE STATE SECURITIES LAWS, OR (2) IN ACCORDANCE WITH THE PROVISIONS OF
REGULATION S, OR (3) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT.
     INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA
P-1
                        FAMILY HOME HEALTH SERVICES INC.
                            SERIES A PREFERRED STOCK
                           PAR VALUE $0.001 PER SHARE

100,000,000 Shares Authorized Common      10,000,000 Shares Authorized Preferred

This is to Certify that _____________________  is the owner of

                --_________________ (____________________) --              fully
paid and               non-assessable Series A Preferred Shares of the above
Corporation transferable only on the books of the Corporation by the holder
hereof in person or by duly authorized Attorney upon surrender of this
Certificate properly endorsed. Witness, the seal of the Corporation and the
signature of its duly authorized officers.

Dated ____________________

Kevin R. Ruark, President                    Vicki L. Welty, Secretary

<PAGE>

FOR VALUE RECEIVED,

hereby sell, assign and transfer unto
________________________________________________________________________________
(______________________________) Shares of the Series A Preferred Shares
represented by the within certificate, and do hereby irrevocably constitute and
appoint
to transfer the said stock on the books of the within named Corporation with
full power of substitution in the premises.

Dated ___________________________________

                                                Signature

                                                Signature Guaranteed By:

                                        2<PAGE>

                                                                     Exhibit 4.2

           THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT
         BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
         (THE "1933 ACT"), OR ANY STATE SECURITIES LAWS AND NEITHER
         SUCH SHARES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD,
         PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A
         REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE
         UNDER THE 1933 ACT AND ANY APPLICABLE STATE SECURITIES LAWS,
         OR (2) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE
         1933 ACT.

         IN ADDITION, A PREFERRED STOCK PURCHASE AGREEMENT DATED AS OF
         MAY 18TH, 2006 (THE "PURCHASE AGREEMENT"), A COPY OF WHICH
         MAY BE OBTAINED FROM THE COMPANY AT ITS PRINCIPAL EXECUTIVE
         OFFICE, CONTAINS CERTAIN ADDITIONAL AGREEMENTS BETWEEN THE
         PARTIES WITH RESPECT TO THIS WARRANT.

                ---------------------------------------

                   FAMILY HOME HEALTH SERVICES INC.

                   COMMON STOCK PURCHASE WARRANT "A"

No. W-____                                   Holder: ___________________________
                                                     ___________________________
                                                     ___________________________
Number of Shares:    _______________________         ___________________________

Original Issue Date: May 24, 2006

Expiration Date:  May 24, 2011

Exercise Price per Share: $ 0.60

Family Home Health Services Inc., a company organized and existing under the
laws of the State of Nevada (the "COMPANY"), hereby certifies that, for value
received, BARRON PARTNERS LP, or its registered assigns (the "WARRANT HOLDER"),
is entitled, subject to the terms set forth below, to purchase from the Company
up to ____________________ (____________) shares (as adjusted from time to time
as provided in Section 7, the "WARRANT SHARES") of common stock, $.001 par value
(the "COMMON STOCK"), of the Company at a price of Sixty Cents ($0.60) per
Warrant Share (as adjusted from time to time as provided in Section 7, the
"EXERCISE PRICE"), at any time and from time to time from and after the date
thereof and through and including 5:00 p.m. New York City time on May 24, 2011
(or eighteen months after effectiveness of a

<PAGE>

Registration Statement subsequent to the issuance hereof (such eighteen months
to be extended by one month for each month or portion of a month during which a
Registration Statement's effectiveness has lapsed or been suspended), whichever
is longer) (the "EXPIRATION DATE"), and subject to the following terms and
conditions:

         1. REGISTRATION OF WARRANT. The Company shall register this Warrant
upon records to be maintained by the Company for that purpose (the "WARRANT
REGISTER"), in the name of the record Warrant Holder hereof from time to time.
The Company may deem and treat the registered Warrant Holder as the absolute
owner hereof for the purpose of any exercise hereof or any distribution to the
Warrant Holder, and for all other purposes, and the Company shall not be
affected by notice to the contrary.

         2. INVESTMENT REPRESENTATION. The Warrant Holder by accepting this
Warrant represents that the Warrant Holder is acquiring this Warrant for its own
account or the account of an affiliate for investment purposes and not with the
view to any offering or distribution and that the Warrant Holder will not sell
or otherwise dispose of this Warrant or the underlying Warrant Shares in
violation of applicable securities laws. The Warrant Holder acknowledges that
the certificates representing any Warrant Shares will bear a legend indicating
that they have not been registered under the United States Securities Act of
1933, as amended (the "1933 Act") and may not be sold by the Warrant Holder
except pursuant to an effective registration statement or pursuant to an
exemption from registration requirements of the 1933 Act and in accordance with
federal and state securities laws. If this Warrant was acquired by the Warrant
Holder pursuant to the exemption from the registration requirements of the 1933
Act afforded by Regulation S thereunder, the Warrant Holder acknowledges and
covenants that this Warrant may not be exercised by or on behalf of a Person
during the one year distribution compliance period (as defined in Regulation S)
following the date hereof. "PERSON" means an individual, partnership, firm,
limited liability company, trust, joint venture, association, corporation, or
any other legal entity.

         3. VALIDITY OF WARRANT AND ISSUE OF SHARES. The Company represents and
warrants that this Warrant has been duly authorized and validly issued and
warrants and agrees that all of the Common Stock that may be issued upon the
exercise of the rights represented by this Warrant will, when issued upon such
exercise, be duly authorized, validly issued, fully paid and nonassessable and
free from all taxes, liens and charges with respect to the issue thereof. The
Company further warrants and agrees that during the period within which the
rights represented by this Warrant may be exercised, the Company will at all
times have authorized and reserved a sufficient number of shares of Common Stock
to provide for the exercise of the rights represented by this Warrant.

         4. REGISTRATION OF TRANSFERS AND EXCHANGE OF WARRANTS.

                  a. Subject to compliance with the legend set forth on the face
of this Warrant, the Company shall register the transfer of any portion of this
Warrant in the Warrant Register, upon surrender of this Warrant with the Form of
Assignment attached hereto duly completed and signed, to the Company at the
office specified in or pursuant to Section 13. Upon any such registration or
transfer, a new warrant to purchase

                                       -2-
<PAGE>

Common Stock, in substantially the form of this Warrant (any such new warrant, a
"NEW WARRANT"), evidencing the portion of this Warrant so transferred shall be
issued to the transferee and a New Warrant evidencing the remaining portion of
this Warrant not so transferred, if any, shall be issued to the transferring
Warrant Holder. The acceptance of the New Warrant by the transferee thereof
shall be deemed the acceptance of such transferee of all of the rights and
obligations of a Warrant Holder.

                  b. This Warrant is exchangeable, upon the surrender hereof by
the Warrant Holder to the office of the Company specified in or pursuant to
Section 13 for one or more New Warrants, evidencing in the aggregate the right
to purchase the number of Warrant Shares which may then be purchased hereunder.
Any such New Warrant will be dated the date of such exchange.

         5. EXERCISE OF WARRANTS.

                  a. Upon surrender of this Warrant with the Form of Election to
Purchase attached hereto duly completed and signed to the Company, at its
address set forth in Section 13, and upon payment and delivery of the Exercise
Price per Warrant Share multiplied by the number of Warrant Shares that the
Warrant Holder intends to purchase hereunder, in lawful money of the United
States of America, in cash or by certified or official bank check or checks, to
the Company, all as specified by the Warrant Holder in the Form of Election to
Purchase, the Company shall promptly (but in no event later than 7 business days
after the Date of Exercise (as defined herein)) issue or cause to be issued and
cause to be delivered to or upon the written order of the Warrant Holder and in
such name or names as the Warrant Holder may designate (subject to the
restrictions on transfer described in the legend set forth on the face of this
Warrant), a certificate for the Warrant Shares issuable upon such exercise, with
such restrictive legend as required by the 1933 Act. Any person so designated by
the Warrant Holder to receive Warrant Shares shall be deemed to have become
holder of record of such Warrant Shares as of the Date of Exercise of this
Warrant.

                  b. A "DATE OF EXERCISE" means the date on which the Company
shall have received (i) this Warrant (or any New Warrant, as applicable), with
the Form of Election to Purchase attached hereto (or attached to such New
Warrant) appropriately completed and duly signed, and (ii) payment of the
Exercise Price for the number of Warrant Shares so indicated by the Warrant
Holder to be purchased.

                  c. This Warrant shall be exercisable at any time and from time
to time for such number of Warrant Shares as is indicated in the attached Form
of Election to Purchase. If less than all of the Warrant Shares which may be
purchased under this Warrant are exercised at any time, the Company shall issue
or cause to be issued, at its expense, a New Warrant evidencing the right to
purchase the remaining number of Warrant Shares for which no exercise has been
evidenced by this Warrant.

                  d. (i) Notwithstanding anything contained herein to the
contrary but subject to Section 6, the holder of this Warrant may, at its
election exercised in its sole discretion, exercise this Warrant in whole or in
part by delivering to the Company a duly

                                      -3-
<PAGE>

executed Form of Election to Purchase marked "Cashless Exercise" and designating
the number of Warrant Shares desired by the Warrant Holder out of the total for
which the Warrant is exercisable and, in lieu of making the cash payment
otherwise contemplated to be made to the Company upon such exercise in payment
of the Aggregate Exercise Price, elect instead to receive upon such exercise the
"NET Number" of shares of Common Stock determined according to the following
formula (a "CASHLESS EXERCISE"):

                          Net Number = (A x (B - C))/B

                  (ii)     For purposes of the foregoing formula:

                           A= the total number shares with respect to which this
                           Warrant is then being exercised.

                           B= the last reported sale price (as reported by
                           Bloomberg) of the Common Stock on the trading day
                           immediately preceding the date of the Exercise
                           Notice.

                           C= the Warrant Exercise Price then in effect at the
                           time of such exercise.

                  e. The Warrant Holder agrees not to elect a Cashless Exercise
for a period of six (6) months from original issue date of this Warrant. The
Warrant Holder also agrees not to elect a Cashless Exercise so long as there is
an effective registration statement for the Warrant Shares.

         6. MAXIMUM EXERCISE. The Warrant Holder shall not be entitled to
exercise this Warrant on a Date of Exercise in connection with that number of
shares of Common Stock which would be in excess of the sum of (i) the number of
shares of Common Stock beneficially owned by the Warrant Holder and its
affiliates on an exercise date, and (ii) the number of shares of Common Stock
issuable upon the exercise of this Warrant with respect to which the
determination of this limitation is being made on an exercise date, which would
result in beneficial ownership by the Warrant Holder and its affiliates of more
than 4.9% of the outstanding shares of Common Stock on such date. This Section 6
may be waived or amended only with the consent of the Warrant Holder and the
consent of holders of a majority of the shares of outstanding Common Stock of
the Company who are not Affiliates. For the purposes of the immediately
preceding sentence, the term "AFFILIATE" shall mean any person: (a) that
directly, or indirectly through one or more intermediaries, controls, or is
controlled by, or is under common control with, the Company; or (b) who
beneficially owns (i) any shares of the Company's Series A Convertible Preferred
Stock, (ii) the Company's Common Stock Purchase Warrant "B" or "C" dated May 24,
2006, or (iii) this Warrant. For the purposes of the immediately preceding
sentence, beneficial ownership shall be determined in accordance with Section
13(d) of the Securities Exchange Act of 1934, as amended (the "1934 Act"), and
Regulation 13d-3 thereunder.

         7. CALL BY THE COMPANY. This Warrant contains a callable feature
requiring the automatic exercise at any time prior to the Expiration Date if the
closing price of the

                                      -4-
<PAGE>

Company's common stock is equal to or in excess of the callable price of $1.02
for a period of at least seventeen (17) out of twenty (20) consecutive trading
days and there is an effective Registration Statement covering the shares of
Common Stock underlying this Warrant ("Automatic Exercise"). Upon occurrence of
the Automatic Exercise, the Company shall provide the Holder with notice of such
Automatic Conversion ("Automatic Exercise Notice"). Upon receipt of the
Automatic Exercise Notice, the Holder must (i) exercise, in whole or in part,
this Warrant within ten (10) days; or (ii) notify the Company of its intent to
transfer this Warrant pursuant to Section 4 of this Warrant. In the event that
the Holder elects to transfer this Warrant pursuant to Section 4 of this
Warrant, then the subsequent holder of this Warrant must exercise this Warrant
on or before the thirtieth (30) day after notification of intent to transfer
this Warrant. In the event that this Warrant is exercised, the Holder must
deliver to the Company at its office at the address set forth in Section 13, on
or before 5:00 p.m., Eastern Time, on the required date, (i) Form of Election to
Purchase properly executed and completed by Holder or an authorized officer
thereof, (ii) a check or wire transfer payable to the order of the Company, in
an amount equal to the product of the Exercise Price MULTIPLIED BY the number of
Warrant Shares specified in the Exercise Notice, AND (iii) this Warrant. If the
Holder does not exercise this Warrant within ten (10) days from receipt of the
Automatic Exercise Notice or, in the event that this Warrant has been
transferred pursuant to Section 4 of this Warrant, the subsequent holder of this
Warrant does not exercise this Warrant within thirty (30) days after
notification of intent to transfer this Warrant, then this Warrant will expire.

Notwithstanding anything to the contrary contained in this Section 7, the
Warrant Holder shall not be required, compelled or otherwise forced to exercise
any portion of this Warrant which would result in beneficial ownership by the
Warrant Holder and its affiliates of more than 4.9% of the then outstanding
number of shares of Common Stock on such date. For the purposes of the
immediately preceding sentence, beneficial ownership shall be determined in
accordance with Section 13(d) of the 1934 Act as amended, and Regulation 13d-3
thereunder.

         8. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF SHARES. The character of
the shares of stock or other securities at the time issuable upon exercise of
this Warrant and the Exercise Price therefore, are subject to adjustment upon
the occurrence of the following events, and all such adjustments shall be
cumulative:

                  a. ADJUSTMENT FOR STOCK SPLITS, STOCK DIVIDENDS,
RECAPITALIZATIONS, ETC. The Exercise Price of this Warrant and the number of
shares of Common Stock or other securities at the time issuable upon exercise of
this Warrant shall be appropriately adjusted to reflect any stock dividend,
stock split, combination of shares, reclassification, recapitalization or other
similar event affecting the number of outstanding shares of stock or securities.

                  b. ADJUSTMENT FOR REORGANIZATION, CONSOLIDATION, MERGER, ETC.
In case of any consolidation or merger of the Company with or into any other
corporation, entity or person, or any other corporate reorganization, in which
the Company shall not be the continuing or surviving entity of such
consolidation, merger or

                                      -5-
<PAGE>

reorganization (any such transaction being hereinafter referred to as a
"REORGANIZATION"), then, in each case, the Warrant Holder, on exercise hereof at
any time after the consummation or effective date of such Reorganization (the
"EFFECTIVE DATE"), shall receive, in lieu of the shares of stock or other
securities at any time issuable upon the exercise of the Warrant issuable on
such exercise prior to the Effective Date, the stock and other securities and
property (including cash) to which such holder would have been entitled upon the
Effective Date if such holder had exercised this Warrant immediately prior
thereto (all subject to further adjustment as provided in this Warrant).

         c. CERTIFICATE AS TO ADJUSTMENTS. In case of any adjustment or
readjustment in the price or kind of securities issuable on the exercise of this
Warrant, the Company will promptly give written notice thereof to the holder of
this Warrant in the form of a certificate, certified and confirmed by the Board
of Directors of the Company, setting forth such adjustment or readjustment and
showing in reasonable detail the facts upon which such adjustment or
readjustment is based.

         d. THE COMPANY FAILS TO MEET CERTAIN INCOME PER SHARE PROJECTIONS. In
the event the Company has income of between $0.098 and $0.059 (40% Decline)
(where such income in this paragraph shall always be defined as operating income
on a fully diluted basis (fully-diluted includes all potentially dilutive
securities and derivatives, such as warrants, options, convertible preferred,
convertible debt, common shares, etc. outstanding (in or out of the money as of
the date of the end of the reported period) as reported for the audited fiscal
year ended December 31st, 2006 from continuing operations before any
non-recurring items) then the then current Exercise Price to the Investor at the
time the audited numbers are reported to the SEC shall be decreased
proportionately by 0% if the income is $0.098 per share or greater and by a
maximum of 40% if the income is $0.059 per share (40% decrease). For example if
the income is $0.078 per share (20% Decline) then the then current Exercise
Price shall be reduced by 20%. In the event the Company has income of any amount
below $0.059 per share, then the then current Exercise Price shall be decreased
by 40% and not more, and if the Company has no income or negative income, then
the then current Exercise Price shall be decreased by 70% and not more. Any
adjustment pursuant to this Section 7(d) shall be made within five business days
of the audited numbers being reported to the SEC.

         e. THE COMPANY SELLS, GRANTS OR ISSUES ANY SHARES, OPTIONS, WARRANTS,
OR ANY INSTRUMENT CONVERTIBLE INTO SHARES OR EQUITY IN ANY FORM BELOW THE
EXERCISE PRICE PER SHARE OF THE WARRANT. Except for the issuance of (i) shares
of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted by a majority of the
non-employee members of the Board of Directors of the Company or a majority of
the members of a committee of non-employee directors established for such
purpose, (ii) securities upon the exercise of or conversion of any securities
issued hereunder, and of any convertible securities, options or warrants issued
and outstanding on the date of this Warrant, provided that such securities have
not been amended since the date of this Warrant to increase the number of such
securities, (iii) securities issued pursuant to acquisitions or strategic
transactions, provided any such issuance shall only be to a person which is,
itself or through its

                                      -6-
<PAGE>

subsidiaries, an operating company in a business synergistic with the business
of the Company and in which the Company receives benefits in addition to the
investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity
whose primary business is investing in securities, and (iv) shares issued in a
firm commitment or best efforts underwritten public offering pursuant to a
registration statement on Form S-1 or Form SB-2 under the Securities Act of
1933, as amended, the public offering price of which was not less than $2.50 per
share (as adjusted for any stock splits, stock dividends, combinations,
subdivisions, recapitalizations or the like) and $20.0 million in the aggregate,
in the event the Company sells, grants or issues any shares, options, warrants,
or any instrument convertible into shares or equity in any form below the
current Exercise Price per share of the warrant, then the current exercise price
per share for the warrant shall be reduced to such lower price.

The provisions of this Section 8(e) shall not apply to any issuance of warrants
or shares for which an adjustment is provided under Sections 8(a), 8(b) or 8(d).

         9. FRACTIONAL SHARES. The Company shall not be required to issue or
cause to be issued fractional Warrant Shares on the exercise of this Warrant.
The number of full Warrant Shares that shall be issuable upon the exercise of
this Warrant shall be computed on the basis of the aggregate number of Warrants
Shares purchasable on exercise of this Warrant so presented. If any fraction of
a Warrant Share would, except for the provisions of this Section 9, be issuable
on the exercise of this Warrant, the Company shall, at its option, (i) pay an
amount in cash equal to the Exercise Price multiplied by such fraction or (ii)
round the number of Warrant Shares issuable, up to the next whole number.

         10. SALE OR MERGER OF THE COMPANY. Upon a Change in Control, the
restriction contained in Section 6 shall immediately be released and the Warrant
Holder will have the right to exercise this Warrant concurrently with such
Change in Control event. For purposes of this Warrant, the term "Change in
Control" shall mean:

         (i) the sale of all then outstanding shares of Common Stock of the
Company or the combined voting power of the then outstanding voting securities
of the Company entitled to vote generally in the election of the directors, in
an amount sufficient to elect a majority of the Company Board of Directors; (ii)
the sale or transfer of stock sufficient to create a new controlling interest in
the Company; or (iii) the consummation of the sale or other disposition of all
or substantially all of the assets or operations of the Company other than: (A)
a sale of assets in a bankruptcy or insolvency proceeding or (B) the
commencement of a bankruptcy case by the Company (or by another entity in the
event of an involuntary filing) under 11 U.S.C. sections 301, 302, 303 and 304,
or the emergence of the Company from bankruptcy.

         11. NOTICE OF INTENT TO SELL OR MERGE THE COMPANY. The Company will
give Warrant Holder ten (10) business days notice before the event of a sale of
all or substantially all of the assets of the Company or the merger or
consolidation of the Company in a transaction in which the Company is not the
surviving entity.

                                      -7-
<PAGE>

         12. ISSUANCE OF SUBSTITUTE WARRANT. In the event of a merger,
consolidation, recapitalization or reorganization of the Company or a
reclassification of Company shares of stock, which results in an adjustment to
the number of shares subject to this Warrant and/or the Exercise Price
hereunder, the Company agrees to issue to the Warrant Holder a substitute
Warrant reflecting the adjusted number of shares and/or Exercise Price upon the
surrender of this Warrant to the Company.

         13. NOTICE. All notices and other communications hereunder shall be in
writing and shall be deemed to have been given (i) on the date they are
delivered if delivered in person; (ii) on the date initially received if
delivered by facsimile transmission followed by registered or certified mail
confirmation; (iii) on the date delivered by an overnight courier service; or
(iv) on the third business day after it is mailed by registered or certified
mail, return receipt requested with postage and other fees prepaid as follows:

                           If to the Company:
                           -----------------

                           Family Home Health Services Inc.
                           801 West Ann Arbor Trail
                           Suite 200
                           Plymouth, MI 48170
                           Attention: President and Chief Executive Officer

                           With a copy to:
                           --------------

                           Butzel Long
                           150 W. Jefferson Ave., Suite 100
                           Detroit, MI 48226-4050
                           Facsimile No.: (313) 225-7080
                           Attn:  Robert A. Hudson, Esq.

                           If to the Warrant Holder:
                           ------------------------

                           Barron Partners LP
                           Barron Capital Advisors LLC,
                           Managing Partner
                           Attn: Andrew Barron Worden
                           730 Fifth Avenue, 9th Floor
                           New York NY 10019
                           tel 212-659-7790

                                      -8-

<PAGE>

         14.      MISCELLANEOUS.

                  a. This Warrant shall be binding on and inure to the benefit
of the parties hereto and their respective successors and permitted assigns.
This Warrant may be amended only by a writing signed by the Company and the
Warrant Holder.

                  b. Nothing in this Warrant shall be construed to give to any
person or corporation other than the Company and the Warrant Holder any legal or
equitable right, remedy or cause of action under this Warrant; this Warrant
shall be for the sole and exclusive benefit of the Company and the Warrant
Holder.

                  c. This Warrant shall be governed by, construed and enforced
in accordance with the internal laws of the State of New York without regard to
the principles of conflicts of law thereof.

                  d. The headings herein are for convenience only, do not
constitute a part of this Warrant and shall not be deemed to limit or affect any
of the provisions hereof.

                  e. In case any one or more of the provisions of this Warrant
shall be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Warrant shall not
in any way be affected or impaired thereby and the parties will attempt in good
faith to agree upon a valid and enforceable provision which shall be a
commercially reasonably substitute therefore, and upon so agreeing, shall
incorporate such substitute provision in this Warrant.

                  f. The Warrant Holder shall not, by virtue hereof, be entitled
to any voting or other rights of a shareholder of the Company, either at law or
equity, and the rights of the Warrant Holder are limited to those expressed in
this Warrant.

                         [SIGNATURES ON FOLLOWING PAGE]

                                      -9-
<PAGE>
         IN WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed by the authorized officer as of the date first above stated.

FAMILY HOME HEALTH SERVICES INC., a Nevada corporation

By:  __________________________________________
Name:  ________________________________________
Its:   President and Chief Executive Officer

844762

                                      -10-
<PAGE>
                          FORM OF ELECTION TO PURCHASE

                  (To be executed by the Warrant Holder to exercise the right to
                  purchase shares of Common Stock under the foregoing Warrant)

To:  FAMILY HOME HEALTH SERVICES, INC.:

                  In accordance with the Warrant enclosed with this Form of
                  Election to Purchase, the undersigned hereby irrevocably
                  elects to purchase ______________ shares of Common Stock
                  ("Common Stock"), $.001 par value, of FAMILY HOME HEALTH
                  SERVICES INC and encloses the warrant and $______ for each
                  Warrant Share being purchased or an aggregate of
                  $________________ in cash or certified or official bank check
                  or checks, which sum represents the aggregate Exercise Price
                  (as defined in the Warrant) together with any applicable taxes
                  payable by the undersigned pursuant to the Warrant.

The undersigned requests that certificates for the shares of Common Stock
issuable upon this exercise be issued in the name of:

                  (Please print name and address)

(Please insert Social Security or Tax Identification Number)

If the number of shares of Common Stock issuable upon this exercise shall not be
all of the shares of Common Stock which the undersigned is entitled to purchase
in accordance with the enclosed Warrant, the undersigned requests that a New
Warrant (as defined in the Warrant) evidencing the right to purchase the shares
of Common Stock not issuable pursuant to the exercise evidenced hereby be issued
in the name of and delivered to:

(Please print name and address)

Dated:  ________________       Name of Warrant Holder:

                                       (Print) ________________________________

                                       (By:)   ________________________________

                                       (Name:) ________________________________

                                       (Title:) _______________________________

                                       Signature must conform in all respects to
                                       name of Warrant Holder as specified on
                                       the face of the Warrant

                                      -11-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]